The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000467336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
12/02/2026
Date registered
Help: Date registered
15/04/2026
Date last updated
Help: Date last updated
14/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
15/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Feasibility and preliminary efficacy of an Occupation-based, Virtual-Reality-based intervention (VR-BrainAware) in inpatient brain injury rehabilitation
Scientific title
Feasibility and preliminary efficacy of an occupation-based, virtual-reality-based intervention (VR-BrainAware) in inpatient brain injury rehabilitation
Additional trial identifiers [1] 316380 0
MRFF ID: 2031492
Universal Trial Number (UTN)
Trial acronym
VR-BrainAware
Related trial records

Health condition
Health condition(s) studied:
Acquired brain injury 340482 0
Condition category
Condition code
Neurological 336686 336686 0 0
Other neurological disorders
Injuries and Accidents 336687 336687 0 0
Other injuries and accidents
Stroke 336688 336688 0 0
Haemorrhagic
Stroke 336689 336689 0 0
Ischaemic

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The research design is a single-centre, two parallel arm, assessor-blinded pilot and feasibility randomised controlled trial. Participants will be randomised to receive either VR-BrainAware plus usual care or usual care alone.

VR-BrainAware

VR-BrainAware is a manualised intervention designed to facilitate opportunities for planning, decision-making and completion of multi-step tasks in virtual scenarios (home and transport simulations). Completion and practice of multi-step tasks are required for interventions targeting executive function impairment including self-awareness, to enable opportunities for making, self-correcting and reflecting upon errors, as well as metacognitive approaches (i.e., feedback, reflection about performance).

The VR-BrainAware tools include a tutorial, facilitator app and two occupation-based simulations (home and transport). The tools were codesigned over a 12-month period. The codesign team included 5 consumers (3 people with TBI, a person with stroke, and significant other), 4 clinicians and 7 clinician/researchers (with backgrounds in occupational therapy, neuropsychology, speech pathology and physiotherapy) as well as 4 technology developers. Codesign team members participated in a series of structured workshops to create the VR-Brain Aware tools. The facilitator app is accessed via a web application whereas the tutorial and the occupation-based scenarios are accessed by users wearing an Occulus 3 virtual reality headset. Users can interact with the virtual environment using minimal hand movements and are not required to use hand controls. The VR-based tutorial prepares users with the necessary skills to interact with the VR environment (e.g., moving, picking up and storing items). The facilitator app enables clinicians to customise interventions based on user needs and to monitor patient performance in the VR scenarios via a separate computer or tablet.

1. Home simulation-based tasks: planning to leave the house, finding and taking necessary items, completing tasks such as identifying and addressing hazards, locking doors or turning off appliances.

2. Public transport-based tasks: navigating the community environment including dealing with hazards, making decisions and dealing with unexpected situations and environmental distractors or events (i.e.. noise, other people). Planning a bus trip including deciding on a route, money/card handling, monitoring time, and taking the planned trip.

VR-Brain Aware will be delivered by qualified, trained occupational therapists. Participants will receive VR-BrainAware twice weekly for up to three weeks. The intervention will be delivered in a inpatient rehabilitation treatment space. Each session will be 1 hour in duration. VR-BrainAware will be provided to the intervention group in addition to usual care, in keeping with the recommended use of VR in addition to traditional approaches in clinical guidelines.
Intervention code [1] 333051 0
Treatment: Other
Intervention code [2] 333553 0
Rehabilitation
Description of the comparator or control
The Usual Care alone group participants will receive their usual, inpatient rehabilitation from the multi-disciplinary rehabilitation team, which may include cognitive rehabilitation as per local practice.
Control group
Active

Outcomes
Primary outcome [1] 344197 0
Acceptability
Timepoint [1] 344197 0
Post intervention-within one week following the three week intervention period.
Primary outcome [2] 344198 0
Feasibility
Timepoint [2] 344198 0
FIM (Post intervention-within one week following the intervention period.). Post-session log (post session-following each intervention session during the intervention period). The Simulator Sickness Questionnaire will be administered before and through-out the intervention period
Secondary outcome [1] 457036 0
Level of Self-Awareness
Timepoint [1] 457036 0
Pre intervention- in the week before the intervention period, and post intervention-within one week following the intervention period
Secondary outcome [2] 457151 0
Transfer of trained skills
Timepoint [2] 457151 0
Pre intervention- in the week before the intervention period, and post intervention-within one week following the intervention period
Secondary outcome [3] 457153 0
Motivation for rehabilitation
Timepoint [3] 457153 0
Pre intervention- in the week before the intervention period, and post intervention-within one week following the intervention period.
Secondary outcome [4] 457154 0
Confidence
Timepoint [4] 457154 0
Post intervention-within one week following the intervention period
Secondary outcome [5] 457173 0
Perceived transition success to home from hospital
Timepoint [5] 457173 0
Post discharge- two to three months after discharge home
Secondary outcome [6] 457174 0
Patient views and experiences of VR-BrainAware
Timepoint [6] 457174 0
Post intervention- within one week following the intervention period and Post discharge- two to three months after discharge home
Secondary outcome [7] 459790 0
Preparedness
Timepoint [7] 459790 0
Post intervention-within one week following the intervention period
Secondary outcome [8] 460373 0
Clinician views and experiences of VR-BrainAware
Timepoint [8] 460373 0
After intervention has been delivered to all participants

Eligibility
Key inclusion criteria
1. Patients with diagnosis of Acquired Brain Injury (ABI) including but not limited to TBI or stroke (by CT/MRI scan or clinical diagnosis) admitted to inpatient rehabilitation
2. Where PTA assessment is applicable, emerged from post-traumatic amnesia (PTA ) or PTA assessment has ceased
3. Aged 16 years or older
4. Expected to have admission length of stay of at least 3 weeks to enable completion of study activities
5. Willing to participate and able to provide written, informed consent
6. Presence of self-awareness impairment (based on report of treating occupational therapist)
7. Expected to tolerate an additional session of therapy for one hour, twice weekly
8. Adequate hand and upper limb function to use the VR (with at least one upper limb), which is: a. Ability to perform a reach (i.e.. could reach for a water-bottle on a table in front), gross grasp and with minimal finger flexion and release (i.e.. could pick up and put down a large plastic cone), b. able to point with one index finger whilst holding forearm in mid position (thumb up and extended)
9. Either independent sitting balance or in absence of independent sitting balance, can maintain an upright position in a hospital bed or chair (i.e., wheelchair) for up to 1 hour
10. Sufficient visual acuity to be able to navigate the physical environment (i.e., find and locate items in a kitchen)

Minimum age
16 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Not medically cleared to participate due to contraindications (e.g. unable to wear VR headset due to craniotomy/bone plate removal, uncontrolled seizures, significant visual impairment, behavioural disturbance)
2. Unable to provide informed consent (e.g. lacking cognitive capacity to provide own consent)
3. Significant visual, perceptual or hearing impairment that prevents participation in VR tasks
4. Fatigue, arousal level, sustained attention or other factors not sufficient to enable tolerance of additional session of therapy for one hour, twice weekly
5. Severe receptive aphasia or inability to comprehend nature of engagement

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Blinding of allocation to group will be undertaken using opaque sealed envelopes prepared by persons not associated with the trial
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Consented participants randomised (1:1) to one of two groups (VR-BrainAware + usual care or usual care only) using stratified randomisation including baseline Awareness Questionnaire (AQ) discrepancy score (less than 9 or greater than or equal to 9) as a factor.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Sample size calculation- Based on historical admissions and our experience with recruitment of people with ABI, we conservatively estimate that 4 people with TBI could be recruited each month (allowing for 60% ineligible or declining), enabling a potential sample of up to 50 over a 12-month recruitment period (25 per randomised arm). This sample size is sufficient to assess acceptability and feasibility (Teare et al., 2014).

Statistical methods and analysis- Descriptive statistics will be used to summarise acceptability and feasibility outcomes for the VR BrainAware intervention group. Between-group differences in health outcomes will be explored.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29087 0
Surgical Treatment and Rehabilitation Service (STARS) - Herston
Recruitment postcode(s) [1] 45377 0
4029 - Herston

Funding & Sponsors
Funding source category [1] 320991 0
Government body
Name [1] 320991 0
Department of Health, Disability and Ageing, Medical Research Future Fund (MRFF)
Country [1] 320991 0
Australia
Primary sponsor type
University
Name
The University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 323689 0
None
Name [1] 323689 0
Address [1] 323689 0
Country [1] 323689 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319524 0
Metro North Health Human Research Ethics Committee A
Ethics committee address [1] 319524 0
Ethics committee country [1] 319524 0
Australia
Date submitted for ethics approval [1] 319524 0
12/11/2025
Approval date [1] 319524 0
25/02/2026
Ethics approval number [1] 319524 0
HREC/2025/MNH/124054

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 147602 0
Dr Emmah Doig
Address 147602 0
Level 7, 296 Herston Road, Surgical Treatment and Rehabilitation Service (STARS), Herston Qld 4029
Country 147602 0
Australia
Phone 147602 0
+61 7 3647 1562
Fax 147602 0
Email 147602 0
Contact person for public queries
Name 147603 0
Dr Emmah Doig
Address 147603 0
Level 7, 296 Herston Road, Surgical Treatment and Rehabilitation Service (STARS), Herston Qld 4029
Country 147603 0
Australia
Phone 147603 0
+61 7 3647 1562
Fax 147603 0
Email 147603 0
Contact person for scientific queries
Name 147604 0
Dr Emmah Doig
Address 147604 0
Level 7, 296 Herston Road, Surgical Treatment and Rehabilitation Service (STARS), Herston Qld 4029
Country 147604 0
Australia
Phone 147604 0
+61 7 3647 1562
Fax 147604 0
Email 147604 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.